What You Should Know:
- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and Labcorp, and existing investors, including Health2047.
- The company has also been awarded a $2.3 million Phase II Small Business Innovation Research (SBIR) Grant
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery
What You Should Know:
- Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
- The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes.
Optimizing Drug Discovery with Simulated
Read More
Medical Nutrition Therapy Startup Fay Emerges from Stealth with $25M
What You Should Know:
- Fay, a San Francisco, CA-based company that focuses on increasing access to medical nutrition therapy emerges from stealth with $25M in funding to tackle America’s growing food crisis.
- The company connects individuals with Registered Dietitians (RDs) for personalized nutrition counseling, all covered by insurance. The insurance-friendly nutrition therapy support platform offers virtual or in-person access to the right RD for individuals’ unique goals
Read More
SmarterDx Nabs $50M for AI-Powered Revenue Integrity for Hospitals
What You Should Know:
- SmarterDx, the leader in clinical AI for revenue integrity and care quality, today announced it has secured $50 million in Series B funding led by Transformation Capital.
- The round also includes continued investments from Bessemer Venture Partners, Flare Capital Partners and Floodgate Fund, bringing total funding to $71 million to date. The investment will drive product
Read More
Brixton Biosciences Secures $33M to Advance Novel Pain Therapies
What You Should Know:
- Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with participation from SV Health Investors, Sparta Group, Excelestar Ventures, PV Capital Management, and Catalyst Health Ventures.
- In addition, Brixton has bolstered its leadership team. Dr. Michael Fishman, a renowned pain management specialist, joins as Chief Medical Officer. Additionally,
Read More
Watershed Health Secures $13.6M to Tackle Uncoordinated Care Crisis
What You Should Know:
- Watershed Health, a New Orleans, LA-based provider of real-time care coordination solutions raises $13.6M in funding led by First Trust Capital Partners with participation from FCA Venture Partners, Create Health Ventures, Impact Engine, 450 Ventures, LDH Ventures II/Launchpad Digital Health, MassMutual Ventures, Capstar Partners and Wanxiang Healthcare Investments.
- The investment will fuel the company's mission to combat uncoordinated care, a major
Read More
Crosby Health Launches Clinical LLM for Automating Healthcare Revenue Cycle with $2.2M in Funding
What You Should Know:
- Crosby Health, a healthtech company pioneering proprietary AI to automate administrative tasks, today announced the launch of its clinical large language model (LLM), Apollo, alongside $2.2M in pre-seed funding led by Amplo Ventures, with participation from NOMO Ventures and angel investors.
-
Read More
Switchboard Health Secures $6.5M to Streamline Specialty Care Access
What You Should Know:
- Switchboard Health, a company transforming specialty care access, has secured $6.5M in Series Seed funding led by First Trust Capital Partners. The investment will fuel the development of their software platform and expand partnerships with health plans and value-based care providers.
- Switchboard's software boasts a powerful provider matching engine. This tool considers factors like location, insurance coverage, cost, quality, and more to find the most
Read More
Triomics Secures $15M to Automate Oncology Workflows with GenAI
What You Should Know:
- Triomics, a company leveraging generative AI to revolutionize cancer care, today announced securing $15 million in funding led by prominent Silicon Valley firms like Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator.
- Triomics partners with leading academic cancer centers and researchers to develop generative AI performance and safety benchmarks and best practices. Triomics partners include the Collaboration for Oncology-focused LLM
Read More
Humanaut Health Secures $8.7M to Expand Premium Longevity Clinics Nationwide
What You Should Know:
- Humanaut Health, a high-end health optimization clinic focused on extending healthy lifespans, today announced securing $8.7M in seed funding.
- The Kabech Fund led the investment round, with participation from Midnight Venture Partners, Humanaut's founders, Tushara Dilanie, and other strategic individual investors.
A Holistic Approach to Longevity
Humanaut's mission is to empower individuals to live longer, healthier lives. Their approach combines
Read More
